BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 12037748)

  • 41. Analysis of treatment outcome for children with recurrent or metastatic hepatoblastoma.
    Matsunaga T; Sasaki F; Ohira M; Hashizume K; Hayashi A; Hayashi Y; Mugishima H; Ohnuma N;
    Pediatr Surg Int; 2003 May; 19(3):142-6. PubMed ID: 12768314
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of neoadjuvant chemotherapy on resectability of stage III and IV hepatoblastoma.
    Venkatramani R; Stein JE; Sapra A; Genyk Y; Jhaveri V; Malogolowkin M; Mascarenhas L
    Br J Surg; 2015 Jan; 102(1):108-13. PubMed ID: 25349947
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Therapy of malignant liver tumors in childhood. An intermediate report of the HB-89 multicenter study of the GPOH].
    von Schweinitz D; Bürger D; Weinel P; Mildenberger H
    Klin Padiatr; 1992; 204(4):214-20. PubMed ID: 1381454
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Successful resection for advanced hepatoblastoma, combined with perioperative chemotherapy.
    Kusano T; Aoki H; Kinjo T; Miyazato H; Shimoji H; Isa T; Muto Y
    J Hepatobiliary Pancreat Surg; 2000; 7(4):410-6. PubMed ID: 11180863
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk-adapted treatment for childhood hepatoblastoma. final report of the second study of the International Society of Paediatric Oncology--SIOPEL 2.
    Perilongo G; Shafford E; Maibach R; Aronson D; Brugières L; Brock P; Childs M; Czauderna P; MacKinlay G; Otte JB; Pritchard J; Rondelli R; Scopinaro M; Staalman C; Plaschkes J;
    Eur J Cancer; 2004 Feb; 40(3):411-21. PubMed ID: 14746860
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma.
    Malogolowkin MH; Katzenstein H; Krailo MD; Chen Z; Bowman L; Reynolds M; Finegold M; Greffe B; Rowland J; Newman K; Womer RB; London WB; Castleberry RP
    J Clin Oncol; 2006 Jun; 24(18):2879-84. PubMed ID: 16782927
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical characteristics and prognosis of patients with hepatoblastoma.
    Jung SE; Kim KH; Kim MY; Kim DY; Lee SC; Park KW; Kim WK
    World J Surg; 2001 Feb; 25(2):126-30. PubMed ID: 11338010
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Avoiding liver transplantation in post-treatment extent of disease III and IV hepatoblastoma.
    El-Gendi A; Fadel S; El-Shafei M; Shawky A
    Pediatr Int; 2018 Sep; 60(9):862-868. PubMed ID: 29906299
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of Pulmonary Metastases in Children With Hepatoblastoma Treated on Children's Oncology Group Protocol AHEP0731 (The Treatment of Children With All Stages of Hepatoblastoma): A Report From the Children's Oncology Group.
    O'Neill AF; Towbin AJ; Krailo MD; Xia C; Gao Y; McCarville MB; Meyers RL; McGahren ED; Tiao GM; Dunn SP; Langham MR; Weldon CB; Finegold MJ; Ranganathan S; Furman WL; Malogolowkin M; Rodriguez-Galindo C; Katzenstein HM
    J Clin Oncol; 2017 Oct; 35(30):3465-3473. PubMed ID: 28892430
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment outcome and pattern of failure in hepatoblastoma treated with a consensus protocol in Hong Kong.
    Liu APY; Ip JJK; Leung AWK; Luk CW; Li CH; Ho KKH; Lo R; Chan EKW; Chan ACY; Chung PHY; Chiang AKS
    Pediatr Blood Cancer; 2019 Jan; 66(1):e27482. PubMed ID: 30270490
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chemotherapeutic approaches for newly diagnosed hepatoblastoma: past, present, and future strategies.
    Trobaugh-Lotrario AD; Katzenstein HM
    Pediatr Blood Cancer; 2012 Nov; 59(5):809-12. PubMed ID: 22648979
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Survival and long-term outcomes in children with hepatoblastoma treated with continuous infusion of cisplatin and doxorubicin.
    Sivaprakasam P; Gupta AA; Greenberg ML; Capra M; Nathan PC
    J Pediatr Hematol Oncol; 2011 Aug; 33(6):e226-30. PubMed ID: 21792028
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chemotherapy effects on hepatoblastoma. A histological study.
    Saxena R; Leake JL; Shafford EA; Davenport M; Mowat AP; Pritchard J; Mieli-Vergani G; Howard ER; Spitz L; Malone M
    Am J Surg Pathol; 1993 Dec; 17(12):1266-71. PubMed ID: 8238734
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Microscopically positive resection margin after hepatoblastoma resection: what is the impact on prognosis? A Childhood Liver Tumours Strategy Group (SIOPEL) report.
    Aronson DC; Weeda VB; Maibach R; Czauderna P; Dall'Igna P; de Ville de Goyet J; Branchereau S; Perilongo G; Brock P; Zsiros J; Semeraro M; Chardot C; Wildhaber B; Morland B; Brugières L;
    Eur J Cancer; 2019 Jan; 106():126-132. PubMed ID: 30528797
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion doxorubicin chemotherapy: a report from the Childrens Cancer Study Group.
    Ortega JA; Krailo MD; Haas JE; King DR; Ablin AR; Quinn JJ; Feusner J; Campbell JR; Lloyd DA; Cherlow J
    J Clin Oncol; 1991 Dec; 9(12):2167-76. PubMed ID: 1720452
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Current chemotherapeutic approaches for hepatoblastoma.
    Watanabe K
    Int J Clin Oncol; 2013 Dec; 18(6):955-61. PubMed ID: 24052132
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Single-agent cisplatin treatment of children with high-risk hepatoblastoma.
    Zhang YT; Feng LH; Zhong XD; Wang LZ; Chang J
    J Pediatr Hematol Oncol; 2014 May; 36(4):271-5. PubMed ID: 24309602
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Current therapeutic strategies for childhood hepatic tumors: surgical and interventional treatments for hepatoblastoma.
    Hishiki T
    Int J Clin Oncol; 2013 Dec; 18(6):962-8. PubMed ID: 24132546
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Redefining the role of doxorubicin for the treatment of children with hepatoblastoma.
    Malogolowkin MH; Katzenstein HM; Krailo M; Chen Z; Quinn JJ; Reynolds M; Ortega JA
    J Clin Oncol; 2008 May; 26(14):2379-83. PubMed ID: 18467729
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tumor necrosis predicts survival following neo-adjuvant chemotherapy for hepatoblastoma.
    Venkatramani R; Wang L; Malvar J; Dias D; Sposto R; Malogolowkin MH; Mascarenhas L
    Pediatr Blood Cancer; 2012 Sep; 59(3):493-8. PubMed ID: 22190448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.